• Product portfolio strengthened
• Nectar Farms order cancelled
• We lower our fair value interval to SEK 4.30 – 6.70 per share

Heliospectra’s report for Q2 included lower revenues but higher gross margins than expected. The order of SEK 72 million from Nectar Farms was also cancelled during the quarter, something we wrote about in our last update. The launch of a newly upgraded helioCORE 2.0 was announced as well, along with a couple of new orders. The order intake excluding the Nectar Farms order is solid yet impacted by the Covid-pandemic, hence we make some revisions to our sales forecast up until the end of next year. We therefore lower our valuation interval to SEK 4.30 – 6.70 per share.

The full report is available here.